A detailed history of Prelude Capital Management, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Prelude Capital Management, LLC holds 22,098 shares of JNJ stock, worth $3.42 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
22,098
Previous 22,098 -0.0%
Holding current value
$3.42 Million
Previous $3.58 Million -0.0%
% of portfolio
0.23%
Previous 0.14%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$145.48 - $167.38 $2.72 Million - $3.13 Million
18,708 Added 551.86%
22,098 $3.58 Million
Q2 2024

Aug 14, 2024

SELL
$144.38 - $157.78 $1.05 Million - $1.15 Million
-7,259 Reduced 68.17%
3,390 $495,000
Q1 2024

May 15, 2024

BUY
$155.22 - $162.74 $1.65 Million - $1.73 Million
10,649 New
10,649 $1.68 Million
Q2 2022

Aug 15, 2022

SELL
$168.19 - $186.01 $785,279 - $868,480
-4,669 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$158.14 - $179.59 $25,776 - $29,273
163 Added 3.62%
4,669 $827,000
Q4 2021

Feb 14, 2022

SELL
$155.93 - $173.01 $873,363 - $969,029
-5,601 Reduced 55.42%
4,506 $771,000
Q3 2021

Nov 15, 2021

SELL
$161.5 - $179.47 $1.69 Million - $1.88 Million
-10,450 Reduced 50.83%
10,107 $1.63 Million
Q2 2021

Aug 16, 2021

BUY
$159.48 - $171.07 $586,407 - $629,024
3,677 Added 21.78%
20,557 $3.39 Million
Q1 2021

May 17, 2021

BUY
$153.07 - $170.48 $1.67 Million - $1.86 Million
10,886 Added 181.61%
16,880 $2.77 Million
Q4 2020

Feb 16, 2021

BUY
$137.11 - $157.38 $329,475 - $378,184
2,403 Added 66.92%
5,994 $943,000
Q3 2020

Nov 16, 2020

SELL
$140.38 - $153.83 $515,896 - $565,325
-3,675 Reduced 50.58%
3,591 $535,000
Q2 2020

Aug 14, 2020

BUY
$128.81 - $155.51 $287,375 - $346,942
2,231 Added 44.31%
7,266 $1.02 Million
Q3 2019

Nov 14, 2019

BUY
$126.95 - $142.14 $639,193 - $715,674
5,035 New
5,035 $651,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $405B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.